A PHASE III RANDOMIZED, OPEN LABEL, MULTI-CENTER STUDY OF THE SAFTEY AND EFFICACY OF APIXABAN FOR THROMBOEMBOLISM PREVENTION VERSUS NO SYSTEMIC ANTICOAGULANT PROPHYLAXIS DURING INDUCTION CHEMOTHERAPY IN CHILDREN WITH NEWLY DIAGNOSED ACUTE
Principal Investigator(s)
Langevin,Anne-Marie R
Funded by
CHILDREN'S HOSPITAL OF PHILADELPHIA
Research Start Date
Status
Active